HLA Typing for Transplant Market worth $1.4 billion by 2030
The report "HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real-time), NGS, Sanger), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), Type (Organ, Soft Tissue), End User (Hospital, Clinic) - Global Forecast to 2030", is projected to reach USD 1.4 billion by 2030 from USD 1.1 billion in 2025, at a CAGR of 6.0% during the forecast period. The HLA typing for transplantation market is expected to experience significant growth during the forecast period due to the escalating volume of organ transplantations globally, an expanding network of transplant and diagnostic centers, and rapid technological advancements in HLA typing methodologies. Furthermore, proactive government initiatives to optimize HLA typing services have bolstered market expansion. Additionally, increased public and private investments in HLA genotyping research have facilitated innovation and development. Industry stakeholders have also sharpened their focus on enhancing manufacturing and distribution efficiencies, particularly in emerging markets, which is further propelling market growth.
Browse 232 market data Tables and 59 Figures spread through 260 Pages and in-depth TOC on "HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real-time), NGS, Sanger), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), Type (Organ, Soft Tissue), End User (Hospital, Clinic) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html
Based on the product & service, the reagents & consumables segment held the largest market share in 2024.
The HLA typing market for transplants is categorized into three segments: software & services, reagents &consumables, and instruments. In 2024, the reagents & consumables segment led in global market share; this growing prominence is primarily driven by a rising demand for precise and rapid identification of HLA alleles, which play a crucial role in transplantation procedures. The ability to quickly and accurately determine HLA compatibility ensures successful organ transplants. It minimizes the risk of rejection, which, in turn, highlights the critical need for advanced reagents and consumables. As healthcare providers increasingly prioritize efficient transplantation processes and improved patient outcomes, this segment is expected to grow substantially, fueled by ongoing innovations and advancements in molecular biology techniques. Such developments will further enhance the effectiveness and reliability of HLA typing, making this an exciting area for investment and development in the coming years.
Based on technology, the molecular assays segment held the largest market share in 2024.
HLA typing for transplantation is categorized into two main segments: molecular assays and non-molecular assays. The molecular-based assays segment commands a significant market share, primarily due to the extensive implementation of advanced molecular technologies, including next-generation sequencing (NGS) and polymerase chain reaction (PCR) methodologies, in transplant facilities and healthcare institutions. These molecular techniques offer superior resolution in HLA typing compared to conventional serological methods, enhancing the accuracy and reliability of donor-recipient matching.
Based on the end user, the independent reference laboratories segment accounted for the largest market share in 2024.
Based on the end user, the HLA typing for the transplant market is categorized into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2024, independent reference laboratories dominated the HLA typing segment of the transplant market due to their ability to handle high sample throughput effectively and specialized expertise in conducting intricate HLA tests and accurately interpreting the results. Their commitment to delivering superior quality HLA typing services further solidified their position in this sector.
North America accounted for the largest HLA typing for transplant market share in 2024.
In 2022, North America held the predominant share of the HLA typing market for transplant, followed closely by Europe. The Asia Pacific region is expected to experience the most rapid growth in this sector throughout the forecast period. North America's supremacy in the HLA typing market can be attributed to several factors: a significant increase in organ transplantation procedures, a robust presence of companies providing transplant diagnostic products—including HLA typing services—and an upsurge in collaborative research efforts aimed at identifying novel HLA genes and elucidating their implications in organ transplantation.
Leading market players in the HLA typing for transplant market
Thermo Fisher Scientific (US), Illumina, Inc. (US), QIAGEN (Germany), CareDx, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Immucor, Inc. (US), Werfen (US), TBG Biotechnology Corporation (Taiwan), Fujirebio (Japan), Omixon Inc. (US), GenDX (Netherlands), BAG Diagnostics GmbH (Germany), Creative Biolabs (US), and PacBio (US)
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the HLA Typing for Transplant Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
